Here, we could show for the first time in a preclinical model that RT combined with DEC and ABC significantly decreases tumor growth and enhances the survival of orthotopic SHH/TP53-mut and Group 3 MB-bearing mice (Figure 2). The gene discussed is TP53; the disease is neoplasm.